RA
CPHR

Raffles Associates’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Raffles Associates’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-447,800
Closed -$2.34M – 70
2016
Q2 		$2.34M Hold
447,800
– – 2.38% 13
2016
Q1 		$2.13M Hold
447,800
– – 2.48% 15
2015
Q4 		$2.1M Hold
447,800
– – 2.55% 14
2015
Q3 		$1.66M Hold
447,800
– – 1.74% 20
2015
Q2 		$3.83M Hold
447,800
– – 3.72% 7
2015
Q1 		$4.06M Sell
447,800
-92,500
-17% -$1.16M 4.26% 6
2014
Q4 		$7.8M Buy
+540,300
New +$7.84M 7.4% 1

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raffles Associates's CPHR Position: Q3 2016 in Review

Raffles Associates sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q3 2016, closing a stake of 447,800 shares — an estimated $2.34M sold.

Raffles Associates first reported a position in CPHR in Q4 2014 and held it in 7 quarters. The position peaked at $7.8M in Q4 2014. 18 funds tracked by Wall St. Rank hold CPHR as of Q3 2016.

  • Raffles Associates reported no remaining Cipher Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
  • Raffles Associates sold 447,800 Cipher Pharmaceuticals Inc. shares in Q3 2016, an estimated $2.34M.
  • Raffles Associates first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 7 quarters.
  • Raffles Associates's Cipher Pharmaceuticals Inc. position peaked at $7.8M in Q4 2014.
  • 18 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q3 2016.

Based on Raffles Associates's 13F filing for Q3 2016, filed 15 Nov 2016.